Foschek 250mg Tablet
Prescription Required
Product introduction
Foschek 250mg Tablet is used to treat increased phosphate level in the blood. It is used in patients who are on dialysis due to severe kidney disease. It inhibits the absorption of phosphate from the intestine and lower the phosphate levels in the blood.
Foschek 250mg Tablet is used to control the levels of phosphate in the blood of adult kidney failure patients on dialysis
Uses of Foschek Tablet
Side effects of Foschek Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Foschek
- Headache
- Nausea
- Vomiting
- Abdominal pain
- Flatulence
- Constipation
- Diarrhea
- Decreased calcium level in blood
How to use Foschek Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Foschek 250mg Tablet is to be taken with food.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Foschek 250mg Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Foschek 250mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Foschek 250mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Foschek 250mg Tablet may cause side effects which could affect your ability to drive.
Dizziness and vertigo (a feeling of dizziness or “spinning”) are uncommon side effects reported by patients taking Foschek 250mg Tablet
Dizziness and vertigo (a feeling of dizziness or “spinning”) are uncommon side effects reported by patients taking Foschek 250mg Tablet
Kidney
SAFE IF PRESCRIBED
Foschek 250mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Foschek 250mg Tablet may not be needed in these patients. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Foschek 250mg Tablet in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Foschek 250mg Tablet
₹8.2/Tablet
Fosbait 250mg Tablet
Panacea Biotec Ltd
₹13.62/tablet
66% costlier
Perito 250mg Tablet
La Renon Healthcare Pvt Ltd
₹1.5/tablet
82% cheaper
Fosend 250mg Tablet
Dr Reddy's Laboratories Ltd
₹10.64/tablet
30% costlier
Quick tips
- Foschek 250mg Tablet is used to control blood phosphate level in patients that are on dialysis treatment.
- You must take it with food and stick to the diet prescribed by your doctor.
- You may develop low levels of calcium, folic acid, and vitamins A,D,E, and K in your blood. Your doctor may prescribe supplements, if necessary.
- Avoid taking any other medicine 1 hour before or 3 hours after taking Foschek 250mg Tablet.
- Inform your doctor if you have nausea, vomiting, constipation, pain in the abdomen, or if you have undergone any major stomach surgery.
- Foschek 250mg Tablet is used to control blood phosphate level in patients that are on dialysis treatment.
- You must take it with food and stick to the diet prescribed by your doctor.
- You may develop low levels of calcium, folic acid, and vitamins A,D,E, and K in your blood. Your doctor may prescribe supplements, if necessary.
- Avoid taking any other medicine 1 hour before or 3 hours after taking Foschek 250mg Tablet.
- Inform your doctor if you have nausea, vomiting, constipation, pain in the abdomen, or if you have undergone any major stomach surgery.
Fact Box
Chemical Class
Organic carbonic acid derivative
Habit Forming
No
Therapeutic Class
OTHERS
Action Class
Phosphorous binder
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 778-79.
- Lanthanum carbonate hydrate. London, England: Shire Pharmaceuticals Limited; 2006 [revised 6 Sep. 2017]. [Accessed 6 Apr. 2019] (online) Available from:
- Medscape. Lanthanum Carbonate. [Accessed 6 Apr. 2019] (online) Available from:
- Lanthanum Carbonate. Shire Way, Lexington: Shire US Inc.; 2004 [revised Feb. 2016]. [Accessed 6 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 6 Apr. 2019] (online) Available from:
Marketer details
Name: Wockhardt Ltd
Address: Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400051, Maharashtra, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
34 people viewed this recentlyMRP
₹81.96
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT
Notify me